PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reports4D Pharma
4D Pharma(LBPS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gilvetmab
urologic neoplasms
,
transitional cell carcinoma
,
urethral neoplasms
,
ureteral neoplasms
,
pelvic neoplasms
,
prostatic neoplasms
,
urinary bladder neoplasms
Microcrystalline cellulose
muscular atrophy
,
tuberculosis
,
lipodystrophy
,
hiv-associated lipodystrophy syndrome
,
chronic obstructive pulmonary disease
,
ulcerative colitis
,
colitis
,
ulcer
,
sepsis
,
atrophy
,
healthy volunteers/patients
,
type 2 diabetes mellitus
,
neoplasms
,
diabetes mellitus
,
multiple myeloma
,
plasma cell neoplasms
,
immunologic deficiency syndromes
,
psoriasis
,
hiv infections
,
infections
,
acquired immunodeficiency syndrome
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Globulin, immune
healthy volunteers/patients
,
atopic dermatitis
,
eczema
,
dermatitis
,
psoriatic arthritis
,
rheumatoid arthritis
Mk3475
neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
malignant mesothelioma
,
mesothelioma
,
colorectal neoplasms
,
hepatocellular carcinoma
,
stomach neoplasms
,
liver neoplasms
,
esophageal squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
non-small-cell lung carcinoma
,
lung neoplasms
MRX0518
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
melanoma
,
oncogenes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use